- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Anlon Healthcare reported strong Q1FY27 results with 163% revenue growth to ₹87.62 Cr and 133% PAT growth to ₹8.28 Cr. The company expanded into Finished Dosage Formulations via subsidiary acquisition.